C9ORF72: What It Is, What It Does, and Why It Matters

Abstract

When the non-coding repeat expansion in the C9ORF72 gene was discovered to be the most frequent cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) in 2011, this gene and its derived protein, C9ORF72, were completely unknown. The mutation appeared to produce both haploinsufficiency and gain-of-function effects in the form of aggregating expanded RNAs and dipeptide repeat proteins (DPRs). An unprecedented effort was then unleashed to decipher the pathogenic mechanisms and the functions of C9ORF72 in order to design therapies. A decade later, while the toxicity of accumulating gain-of-function products has been established and therapeutic strategies are being developed to target it, the contribution of the loss of function starts to appear more clearly. This article reviews the current knowledge about the C9ORF72 protein, how it is affected by the repeat expansion in models and patients, and what could be the contribution of its haploinsufficiency to the disease in light of the most recent findings. We suggest that these elements should be taken into consideration to refine future therapeutic strategies, compensating for the decrease of C9ORF72 or at least preventing a further reduction.

References 171

1. 1.

   Abo-Rady M. Kalmbach N. Pal A. Schludi C. Janosch A. Richter T. (2020 ). Knocking out C9ORF72 exacerbates axonal trafficking defects associated with hexanucleotide repeat expansion and reduces levels of heat shock proteins. Stem Cell Rep. 14 390–405.

   Not in our library10.1016/j.stemcr.2020.01.010

2. 2.

   Al-Sarraj S. King A. Troakes C. Smith B. Maekawa S. Bodi I. (2011 ). p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol. (Berl.) 122 691–702.

   Not in our library10.1007/s00401-011-0911-2

3. 3.

   Amick J. Roczniak-Ferguson A. Ferguson S. M. (2016 ). C9orf72 binds SMCR8, localizes to lysosomes, and regulates mTORC1 signaling. Mol. Biol. Cell 27 3040–3051.

   Not in our library10.1091/mbc.e16-01-0003

4. 4.

   Aoki Y. Manzano R. Lee Y. Dafinca R. Aoki M. Douglas A. G. L. (2017 ). C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia. Brain J. Neurol. 140 887–897.

   Not in our library10.1093/brain/awx024

5. 5.

   Arai T. Hasegawa M. Akiyama H. Ikeda K. Nonaka T. Mori H. (2006 ). TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351 602–611.

   Not in our library10.1016/j.bbrc.2006.10.093

6. 6.

   Ash P. E. A. Bieniek K. F. Gendron T. F. Caulfield T. Lin W.-L. Dejesus-Hernandez M. (2013 ). Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77 639–646.

   Not in our library10.1016/j.neuron.2013.02.004

7. 7.
   C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production and glomerulonephropathy in mice · 2016

   No notice
8. 8.

   Atkinson R. A. K. Fernandez-Martos C. M. Atkin J. D. Vickers J. C. King A. E. (2015 ). C9ORF72 expression and cellular localization over mouse development. Acta Neuropathol. Commun. 31 1–11.

   Not in our library10.1186/s40478-015-0238-7

9. 9.

   Balendra R. Isaacs A. M. (2018 ). C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat. Rev. Neurol. 14 544–558.

   Not in our library10.1038/s41582-018-0047-2

10. 10.

    Beck J. Poulter M. Hensman D. Rohrer J. D. Mahoney C. J. Adamson G. (2013 ). Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am. J. Hum. Genet. 92 345–353.

    Not in our library10.1016/j.ajhg.2013.01.011

11. 11.

    Belzil V. V. Bauer P. O. Gendron T. F. Murray M. E. Dickson D. Petrucelli L. (2014 ). Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients. Brain Res. 1584 15–21.

    Not in our library10.1016/j.brainres.2014.02.015

12. 12.
    Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood · 2013

    No notice
13. 13.
    Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways · 2016

    No notice
14. 14.

    Braems E. Swinnen B. Van Den Bosch L. (2020 ). C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD? Acta Neuropathol. (Berl.) 140 625–643.

    Not in our library10.1007/s00401-020-02214-x

15. 15.

    Burberry A. Suzuki N. Wang J.-Y. Moccia R. Mordes D. A. Stewart M. H. (2016 ). Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci. Transl. Med. 8 ra93–ra347.

    Not in our library10.1126/scitranslmed.aaf6038

16. 16.

    Burberry A. Wells M. F. Limone F. Couto A. Smith K. S. Keaney J. (2020 ). C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature 582 89–94.

    Not in our library10.1038/s41586-020-2288-7

17. 17.

    Burrell J. R. Halliday G. M. Kril J. J. Ittner L. M. Götz J. Kiernan M. C. (2016 ). The frontotemporal dementia-motor neuron disease continuum. Lancet 388 919–931.

    Not in our library10.1016/s0140-6736(16)00737-6

18. 18.

    Chai N. Haney M. S. Couthouis J. Morgens D. W. Benjamin A. Wu K. (2020 ). Genome-wide synthetic lethal CRISPR screen identifies FIS1 as a genetic interactor of ALS-linked C9ORF72. Brain Res. 1728:146601.

    Not in our library10.1016/j.brainres.2019.146601

19. 19.

    Charcot J.-M. (1869 ). Deux cas d’atrophie musculaire progressive avec lesions de la substance grice et des faisceaux anterolateraux de la moelle epiniere. Arch. Physiol. Norm. Pathol. 354:744.

    Not in our library

20. 20.

    Chen Y. Lin Z. Chen X. Cao B. Wei Q. Ou R. (2016 ). Large C9orf72 repeat expansions are seen in Chinese patients with sporadic amyotrophic lateral sclerosis. Neurobiol. Aging 38 217.e15–217.e22.

    Not in our library10.1016/j.neurobiolaging.2015.11.016

21. 21.

    Chew J. Gendron T. F. Prudencio M. Sasaguri H. Zhang Y.-J. Castanedes-Casey M. (2015 ). C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science 348 1151–1154.

    Not in our library10.1126/science.aaa9344

22. 22.
    A complex of C9ORF72 and p62 uses arginine methylation to eliminate stress granules by autophagy · 2018

    No notice
23. 23.

    Choi S. Y. Lopez-Gonzalez R. Krishnan G. Phillips H. L. Li A. N. Seeley W. W. (2019 ). C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat. Neurosci. 22 851–862.

    Not in our library10.1038/s41593-019-0397-0

24. 24.

    Ciura S. Lattante S. Le Ber I. Latouche M. Tostivint H. Brice A. (2013 ). Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann. Neurol. 74 180–187.

    Not in our library10.1002/ana.23946

25. 25.

    Cooper-Knock J. Higginbottom A. Connor-Robson N. Bayatti N. Bury J. J. Kirby J. (2013 ). C9ORF72 transcription in a frontotemporal dementia case with two expanded alleles. Neurology 81 1719–1721.

    Not in our library10.1212/01.wnl.0000435295.41974.2e

26. 26.
    Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions · 2014

    No notice
27. 27.

    Davidson Y. S. Robinson A. C. Rollinson S. Pickering-Brown S. Xiao S. Robertson J. (2018 ). Immunohistochemical detection of C9orf72 protein in frontotemporal lobar degeneration and motor neurone disease: patterns of immunostaining and an evaluation of commercial antibodies. Amyotroph. Lateral Scler. Front. Degener. 19 102–111.

    Not in our library10.1080/21678421.2017.1359304

28. 28.

    De Franceschi N. Wild K. Schlacht A. Dacks J. B. Sinning I. Filippini F. (2014 ). Longin and GAF domains: structural evolution and adaptation to the subcellular trafficking machinery. Traffic Cph. Den. 15 104–121.

    Not in our library10.1111/tra.12124

29. 29.

    DeJesus-Hernandez M. Mackenzie I. R. Boeve B. F. Boxer A. L. Baker M. Rutherford N. J. (2011 ). Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72 245–256.

    Not in our library10.1016/j.neuron.2011.09.011

30. 30.

    Deng Z. Sheehan P. Chen S. Yue Z. (2017 ). Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease? Mol. Neurodegener. 12:90.

    Not in our library10.1186/s13024-017-0232-6

31. 31.

    Dickson D. W. Baker M. C. Jackson J. L. DeJesus-Hernandez M. Finch N. A. Tian S. (2019 ). Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers. Acta Neuropathol. Commun. 7:150.

    Not in our library10.1186/s40478-019-0797-0

32. 32.

    Dols-Icardo O. García-Redondo A. Rojas-García R. Sánchez-Valle R. Noguera A. Gómez-Tortosa E. (2014 ). Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia. Hum. Mol. Genet. 23 749–754.

    Not in our library10.1093/hmg/ddt460

33. 33.

    Dong W. Ma Y. Guan F. Zhang X. Chen W. Zhang L. (2020a ). Ablation of C9orf72 together with excitotoxicity induces ALS in rats. FEBS J. 288 1712–1723.

    Not in our library10.1111/febs.15501

34. 34.

    Dong W. Zhang L. Sun C. Gao X. Guan F. Li J. (2020b ). Knock in of a hexanucleotide repeat expansion in the C9orf72 gene induces ALS in rats. Anim. Models Exp. Med. 3 237–244.

    Not in our library10.1002/ame2.12129

35. 35.

    Donnelly C. J. Zhang P.-W. Pham J. T. Haeusler A. R. Heusler A. R. Mistry N. A. (2013 ). RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80 415–428.

    Not in our library10.1016/j.neuron.2013.10.015

36. 36.

    Douglas A. G. L. (2018 ). Non-coding RNA in C9orf72-related amyotrophic lateral sclerosis and frontotemporal dementia: A perfect storm of dysfunction. Non-Coding RNA Res. 3 178–187.

    Not in our library10.1016/j.ncrna.2018.09.001

37. 37.

    D’Souza-Schorey C. Chavrier P. (2006 ). ARF proteins: roles in membrane traffic and beyond. Nat. Rev. Mol. Cell Biol. 7 347–358.

    Not in our library10.1038/nrm1910

38. 38.

    Fang F. Al-Chalabi A. Ronnevi L.-O. Turner M. R. Wirdefeldt K. Kamel F. (2013 ). Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden. Amyotroph. Lateral Scler. Front. Degener. 14 362–368.

    Not in our library10.3109/21678421.2013.775309

39. 39.

    Farg M. A. Sundaramoorthy V. Sultana J. M. Yang S. Atkinson R. A. K. Levina V. (2014 ). C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum. Mol. Genet. 23 3579–3595.

    Not in our library10.1093/hmg/ddu068

40. 40.

    Ferguson R. Serafeimidou-Pouliou E. Subramanian V. (2016 ). Dynamic expression of the mouse ortholog of the human amyotropic lateral sclerosis associated gene C9orf72 during central nervous system development and neuronal differentiation. J. Anat. 229 871–891.

    Not in our library10.1111/joa.12526

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.